Peter W. Bergum

1.1k total citations
20 papers, 913 citations indexed

About

Peter W. Bergum is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter W. Bergum has authored 20 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter W. Bergum's work include Blood Coagulation and Thrombosis Mechanisms (13 papers), Hemophilia Treatment and Research (5 papers) and Protease and Inhibitor Mechanisms (4 papers). Peter W. Bergum is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (13 papers), Hemophilia Treatment and Research (5 papers) and Protease and Inhibitor Mechanisms (4 papers). Peter W. Bergum collaborates with scholars based in United States and France. Peter W. Bergum's co-authors include G P Vlasuk, George P. Vlasuk, Michael Cappello, Peter J. Hotez, Sriram Krishnaswamy, Steven L. Maki, Samuel I. Rapaport, Yannick Gansemans, Laurent Jespers and Ignace Lasters and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Peter W. Bergum

20 papers receiving 845 citations

Peers

Peter W. Bergum
L I Garfinkel United States
Elka M. Nutt United States
Karen P. Fong United States
Alan M. Seddon United Kingdom
Marla Lay United States
Stephanie L. Williams United States
Emmanuel Tupin United States
L I Garfinkel United States
Peter W. Bergum
Citations per year, relative to Peter W. Bergum Peter W. Bergum (= 1×) peers L I Garfinkel

Countries citing papers authored by Peter W. Bergum

Since Specialization
Citations

This map shows the geographic impact of Peter W. Bergum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Bergum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Bergum more than expected).

Fields of papers citing papers by Peter W. Bergum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Bergum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Bergum. The network helps show where Peter W. Bergum may publish in the future.

Co-authorship network of co-authors of Peter W. Bergum

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Bergum. A scholar is included among the top collaborators of Peter W. Bergum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Bergum. Peter W. Bergum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bergum, Peter W., et al.. (2002). Nematode Anticoagulant Protein c2 Reveals a Site on Factor Xa That Is Important for Macromolecular Substrate Binding to Human Prothrombinase. Journal of Biological Chemistry. 277(29). 26689–26698. 72 indexed citations
4.
Tamura, Susan Y., Odile E. Levy, John Reiner, et al.. (2000). Guanylpiperidine peptidomimetics: potent and selective bis-cation inhibitors of factor Xa. Bioorganic & Medicinal Chemistry Letters. 10(8). 745–749. 12 indexed citations
5.
Tamura, Susan Y., Erick A. Goldman, Peter W. Bergum, & J. Edward Semple. (1999). Novel benzo-fused lactam scaffolds as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(17). 2573–2578. 28 indexed citations
6.
Betz, Andreas, George P. Vlasuk, Peter W. Bergum, & Sriram Krishnaswamy. (1997). Selective Inhibition of the Prothrombinase Complex:  Factor Va Alters Macromolecular Recognition of a Tick Anticoagulant Peptide Mutant by Factor Xa,. Biochemistry. 36(1). 181–191. 25 indexed citations
7.
Tulinsky, A., George P. Vlasuk, Daniel A. Pearson, et al.. (1996). Synthesis, structure, and structure‐activity relationships of divalent thrombin inhibitors containing an α‐keto‐amide transition‐state mimetic. Protein Science. 5(3). 422–433. 27 indexed citations
8.
Cappello, Michael, et al.. (1996). Isolation and Characterization of the Tsetse Thrombin Inhibitor: A Potent Antithrombotic Peptide from the Saliva of Glossina morsitans morsitans. American Journal of Tropical Medicine and Hygiene. 54(5). 475–480. 62 indexed citations
9.
Bergum, Peter W., Yannick Gansemans, Laurent Jespers, et al.. (1996). Anticoagulant repertoire of the hookworm Ancylostoma caninum.. Proceedings of the National Academy of Sciences. 93(5). 2149–2154. 206 indexed citations
10.
Håkansson, Kjell Erik Julius, A. Tulinsky, Matthew M. Abelman, et al.. (1995). Crystallographic structure of a peptidyl keto acid inhibitor and human α-thrombin. Bioorganic & Medicinal Chemistry. 3(8). 1009–1017. 20 indexed citations
11.
Cappello, Michael, et al.. (1995). Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa.. Proceedings of the National Academy of Sciences. 92(13). 6152–6156. 143 indexed citations
12.
Krishnaswamy, Sriram, George P. Vlasuk, & Peter W. Bergum. (1994). Assembly of the Prothrombinase Complex Enhances the Inhibition of Bovine Factor Xa by Tick Anticoagulant Peptide. Biochemistry. 33(25). 7897–7907. 47 indexed citations
13.
14.
Rehberg, E.F., et al.. (1989). Construction of a tissue plasminogen activator gene having unique restriction sites to facilitate domain manipulation: a model for the analysis of multi-domain proteins. Protein Engineering Design and Selection. 2(5). 371–377. 15 indexed citations
15.
Bergum, Peter W., et al.. (1988). Neutralization by Plasminogen Activator Inhibitor-1 ofMutants of Tissue Plasminogen Activator. Enzyme. 40(2-3). 122–129. 6 indexed citations
16.
Erickson, L.A., Peter W. Bergum, Nicole Y. Thériault, et al.. (1987). ENHANCEMENT AND INHIBITION OF THE ACTIVITY OF RECOMBINANT ANALOGS OF TISSUE PLASMINOGEN ACTIVATOR. Thrombosis and Haemostasis. 2 indexed citations
17.
Pui, Ching‐Hon, C Chesney, Peter W. Bergum, Carl W. Jackson, & Samuel I. Rapaport. (1986). Lack of pathogenetic role of proteins C and S in thrombosis associated with asparaginase‐prednisone‐vincristine therapy for leukaemia. British Journal of Haematology. 64(2). 283–290. 24 indexed citations
18.
Epstein, David J., Peter W. Bergum, S Paul Bajaj, & Samuel I. Rapaport. (1984). Radioimmunoassays for Protein C and Factor X: Plasma Antigen Levels in Abnormal Hemostatic States. American Journal of Clinical Pathology. 82(5). 573–581. 46 indexed citations
19.
Lang, T., et al.. (1982). The labeling of rabbit neutrophils with [111In]oxine. Journal of Immunological Methods. 51(3). 293–305. 19 indexed citations
20.
Betz, A. C., G P Vlasuk, Peter W. Bergum, & Sriram Krishnaswamy. (1971). Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.. PubMed. 36(1). 181–6. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026